Retraction of: "Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis"
- PMID: 37712218
- DOI: 10.23736/S2724-5683.23.06421-9
Retraction of: "Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis"
Abstract
The paper entitled "Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis" by Renato De Vecchis et al., which was published in Minerva Cardioangiologica 2018 October;66(5):659-70, has been retracted by the Publisher due to plagiarism.
Retraction of
-
Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.Minerva Cardioangiol. 2018 Oct;66(5):659-670. doi: 10.23736/S0026-4725.17.04382-1. Epub 2017 Apr 10. Minerva Cardioangiol. 2018. Retraction in: Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06421-9. PMID: 28398017 Retracted. Review.
Similar articles
-
Retraction of: "Antihypertensive effect of sacubitril/valsartan: a meta-analysis".Minerva Cardiol Angiol. 2023 Oct;71(5):609. doi: 10.23736/S2724-5683.23.06420-7. Minerva Cardiol Angiol. 2023. PMID: 37712221
-
Retraction of: "Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials".Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06418-9. Minerva Cardiol Angiol. 2023. PMID: 37712219
-
Retraction of: "Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fraction".Minerva Cardiol Angiol. 2023 Oct;71(5):609. doi: 10.23736/S2724-5683.23.06419-0. Minerva Cardiol Angiol. 2023. PMID: 37712220
-
Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.Minerva Cardioangiol. 2018 Oct;66(5):659-670. doi: 10.23736/S0026-4725.17.04382-1. Epub 2017 Apr 10. Minerva Cardioangiol. 2018. Retraction in: Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06421-9. PMID: 28398017 Retracted. Review.
-
Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.Minerva Cardioangiol. 2017 Aug;65(4):427-442. doi: 10.23736/S0026-4725.16.04293-6. Epub 2016 Dec 13. Minerva Cardioangiol. 2017. Retraction in: Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06418-9. PMID: 27958695 Retracted. Review.
References
Publication types
LinkOut - more resources
Full Text Sources